- Email:
Custom CNS Disease Modeling Services
Introduction
Custom CNS Disease Modeling employs hiPSCs and 3D bioengineering to simulate the human brain microenvironment. Studies show 3D organoids outperform animal models in recapitulating human-specific neurodegeneration. Creative Biolabs integrates CRISPR editing and advanced organoid technology to provide stable, high‑fidelity disease models. These solutions support drug target discovery, BBB permeability evaluation, and neurotoxicity testing, bridging preclinical research and clinical translation to efficiently accelerate CNS drug development.
Discover How We Can Help - Request a Consultation →
Custom CNS Disease Modeling Services
Our Custom CNS Disease Modeling Service employs human iPSC-derived 3D neural models to faithfully replicate the pathological features of human central nervous system disorders. We offer highly reproducible, patient-specific models tailored for mechanistic research, drug screening, and therapeutic validation.
Fig.1 An example of a method for brain organoid specification.1
Custom Disease Models
Alzheimer's Disease Modeling
Recapitulates Aβ plaque deposition, tau hyperphosphorylation, neurodegeneration, and synaptic loss, ideal for drug screening and pathological mechanism studies.
Huntington's Disease Modeling
Simulates mutant huntingtin aggregation, neuronal dysfunction, and degeneration, supporting research on disease progression and neuroprotective drug development.
Parkinson's Disease Modeling
Recreates dopaminergic neuron loss, α-synuclein aggregation, and motor-related deficits, suitable for drug efficacy evaluation and cell therapy validation.
Applications
- Disease onset and progression analysis
- High-throughput drug screening and neurotoxicity assessment
- Gene therapy and gene editing validation
- Patient-derived precision medicine research
Workflow
Our service is built on a rigorous, consultative framework designed to ensure the resulting model meets the specific physiological requirements of your therapeutic area.
What We Can Offer
As a global leader in neuroscience innovation, Creative Biolabs provides a suite of customized CNS modeling capabilities tailored to your specific research endpoints. We combine industrial-scale production with the precision of a boutique laboratory.
One-stop Modeling Service
All-sided support from initial gene editing and hiPSC reprogramming to large-scale 3D organoid maturation and high-throughput screening.
High-Standard Quality Control
Implementation of Quality-by-Design (QbD) and Process Analytical Techniques (PAT) to ensure the functional maturity and structural integrity of every neural model.
Customized Genomic Engineering
Precision codon optimization and CRISPR/Cas9-mediated gene editing to facilitate the expression of specific disease-linked variants in selected neural lineages.
Large-Scale Production Capability
Automated fabrication platforms capable of generating thousands of homogenous brain organoids simultaneously, supporting massive compound library screenings.
Strict Aseptic & Stability Protocols
Rigorous verification procedures to guarantee the stability and longevity of neural cultures throughout long-term maturation phases.
Flexible Operational Modes
Ability to run assays in batch, fed-batch, or continuous monitoring modes using real-time imaging and MEA measurement systems.
Expert Documentation
All-side assessment and approval of cell bank origins and characterization data by our internal Quality Assurance (QA) service to support your IND filings.
Experience the Creative Biolabs Advantage - Get a Quote Today →
Customer Reviews
FAQs
Q: What cell sources are compatible with your custom modeling?
A: We primarily utilize human iPSCs (either client-provided or from our internal library), but can also work with primary cells or immortalized lines depending on the specific application.
Q: Can your platform model the Blood-Brain Barrier (BBB)?
A: Yes, we offer both Transwell-based systems and advanced BBB-on-a-chip models that incorporate fluidic shear stress to simulate physiological transport.
Q: How do you ensure the reproducibility of 3D brain organoids?
A: Creative Biolabs utilizes automated seeding and high-content imaging platforms to standardize organoid growth, reducing the batch-to-batch variability common in manual cultures.
Q: Are your models suitable for high-throughput screening (HTS)?
A: Yes. We have optimized our 2D and 3D neural differentiation protocols for 96-well and 384-well formats to support large-scale compound libraries.
Q: Can you introduce specific genetic mutations into the models?
A: Yes, we use CRISPR/Cas9 technology to create precise knock-in or knock-out models, allowing you to study the impact of specific risk variants like APOE4 or LRRK2.
Creative Biolabs provides a suite of CNS modeling services, including iPSC differentiation, 3D STEMOD™ organoids, BBB modeling, and phenotypic screening. Our platform is designed to turn biological complexity into clinical leads.
Contact Our Team for More Information and to Discuss Your Project →
Reference
- Larriba-González, Teresa, et al. "Modeling neurodegenerative diseases with brain organoids: from development to disease applications." Frontiers in Cell and Developmental Biology 13 (2025): 1663286. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fcell.2025.1663286.
For Research Use Only. Not For Clinical Use.